Skip to main content

Health condition · Clinically reviewed

Pancreatic cysts, from incidental finding to a risk-based plan.

Most are found by accident and most are not cancer - but the type of cyst you have matters. Here is how it's worked out, and what happens next.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against European, IAP and AGA consensus guidelines you can see at the end.

  • 03

    Current for 2026

    Reflects modern risk-stratified surveillance and resection criteria for cystic pancreatic lesions.

Key facts

Pancreatic cysts at a glance.

The essentials, in plain English - what they are, the main types, and how they're assessed and managed today.

  • What it is

    A fluid-filled sac in or on the pancreas, increasingly picked up incidentally on scans done for unrelated reasons.

  • Main types

    Pseudocysts (from pancreatitis), serous cystadenomas (benign) and mucinous or IPMN lesions (malignant potential).

  • Detection

    Most are found incidentally on a CT or MRI ordered for something else, not because of symptoms.

  • Key investigation

    Endoscopic ultrasound with fine-needle aspiration (EUS-FNA) analyses cyst fluid for CEA, amylase and cytology.

  • Malignant potential

    Serous cysts are almost always benign; mucinous cystic neoplasms and IPMN carry a real, if often low, cancer risk.

  • Management

    Risk-stratified - surveillance imaging for low-risk lesions, resection for those with high-risk features.

Why this guide matters

An incidental finding that still needs the right answer.

A pancreatic cyst is common and usually reassuring - but getting the type and risk right matters. The three points below shape everything else on this page.

  • Most cysts are found by accident

    A scan for something unrelated is how the majority of pancreatic cysts come to light - not because of symptoms.

  • Type determines risk

    Serous cysts are almost always benign; mucinous and IPMN lesions need proper risk assessment before anyone can say the same.

  • Surveillance or surgery, not guesswork

    International consensus guidelines set out worrying features and high-risk stigmata that decide the plan - not the size of the cyst alone.

How the diagnosis is made

From incidental scan to a clear plan.

The steps a UK specialist team will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    Incidental detection

    Most pancreatic cysts are spotted on a CT or MRI scan requested for an unrelated reason - not because of symptoms.

  2. 02

    Assessing

    Clinical history and exam

    A history of pancreatitis, alcohol use, family cancer history and any pain, weight loss or jaundice shapes the next steps.

  3. 03

    Assessing

    Cross-sectional imaging

    Dedicated CT or MRI/MRCP characterises the cyst - size, location, septations, duct involvement and any solid component.

  4. 04

    Confirming

    Endoscopic ultrasound with FNA

    EUS-FNA samples cyst fluid for CEA, amylase and cytology - the best way to distinguish mucinous from non-mucinous lesions.

  5. 05

    Confirming

    Worrying features and stigmata

    Size, main duct dilatation, mural nodules and abnormal cytology are weighed against international consensus criteria.

  6. 06

    Deciding

    Specialist HPB MDT review

    Complex or higher-risk cysts are discussed at a hepatobiliary and pancreatic multidisciplinary team meeting.

  7. 07

    Deciding

    Agreeing a risk-based plan

    The outcome is either a surveillance imaging schedule or a referral for surgical or endoscopic treatment.

Typical timeline: an incidental finding to a confirmed plan within a few weeks.

Symptoms

What pancreatic cysts actually feel like.

For most people, nothing at all. For a minority, pain, pressure or jaundice. And the features that mean it's time to escalate.

  • No symptoms at all

    The great majority of pancreatic cysts cause no symptoms and are found only because a scan was done for something else.

  • Abdominal or back pain

    Larger cysts can cause dull upper abdominal or back pain, sometimes worse after eating.

  • Nausea and early fullness

    A cyst pressing on the stomach or duodenum can cause nausea, bloating or feeling full quickly.

  • Palpable mass

    Very large cysts, particularly pseudocysts, can occasionally be felt as a mass in the upper abdomen.

  • Jaundice

    Yellowing of the skin or eyes suggests the cyst is compressing the bile duct - this needs prompt assessment.

  • Pancreatitis symptoms

    Severe upper abdominal pain radiating to the back can signal a pseudocyst related to acute or chronic pancreatitis.

  • Unexplained weight loss

    Weight loss alongside a known cyst is taken seriously and prompts closer assessment for malignant change.

  • Red flag - jaundice or rapid growth

    New jaundice, rapid growth or new diabetes alongside a pancreatic cyst warrants urgent specialist review.

Treatment

How pancreatic cysts are managed in the UK.

Risk-stratified from start to finish - surveillance for low-risk lesions, and resection or drainage where features warrant it.

  • Surveillance imaging

    Regular CT or MRI at set intervals for low-risk cysts, including many mucinous and IPMN lesions without worrying features.

  • EUS-FNA fluid analysis

    Cyst fluid CEA, amylase and cytology help confirm the cyst type and refine the malignant-risk assessment.

  • Risk stratification

    Size, main duct involvement, mural nodules and cytology are weighed against worrying features and high-risk stigmata.

  • Surgical resection

    Recommended when high-risk features suggest malignancy or significant malignant potential - performed by specialist HPB surgeons.

  • Endoscopic drainage

    For symptomatic pseudocysts - fluid is drained endoscopically, often via a stent placed between the cyst and the stomach or duodenum.

  • Treating pancreatitis

    Where a pseudocyst has formed after pancreatitis, managing the underlying cause reduces the chance of recurrence.

  • Specialist HPB MDT

    Complex or borderline cysts are discussed by a commissioned hepatobiliary and pancreatic multidisciplinary team before any decision is made.

  • Post-resection surveillance

    After surgery, the remaining pancreas is still monitored - IPMN in particular can recur elsewhere in the gland.

What this guide is based on

The sources behind every claim on this page.

International consensus guidelines and specialist society standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your GP or specialist team knows your scans and history and can tell you which parts apply to you. If in doubt, get seen.

  • International Association of Pancreatology (IAP). Fukuoka/Kyoto consensus guidelines for IPMN and MCN.

  • European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms.

  • American Gastroenterological Association (AGA). Guideline on the diagnosis and management of pancreatic cysts.

  • NICE and British Society of Gastroenterology. Pathways for suspected and confirmed pancreatic disease.

Red flags

When a pancreatic cyst needs urgent attention.

Most pancreatic cysts are safely watched. These are the features that change that - and where a specialist opinion is needed promptly.

  • New jaundice

    Yellowing of the skin or eyes suggests bile duct compression and needs urgent specialist assessment.

  • Rapid cyst growth

    A cyst enlarging quickly on serial imaging is a recognised trigger for earlier intervention.

  • Main duct dilatation

    Main pancreatic duct dilatation of 10mm or more is a high-risk stigma warranting resection in most guidelines.

  • Enhancing mural nodule

    A contrast-enhancing mural nodule is one of the strongest predictors of malignant or high-grade change.

  • Positive or suspicious cytology

    High-grade dysplasia or malignant cells on EUS-FNA cytology should prompt urgent surgical referral.

  • New-onset diabetes

    Recent-onset diabetes alongside a known pancreatic cyst can be an early marker of malignant transformation.

  • Acute pancreatitis from the cyst

    A cyst that has triggered an episode of pancreatitis needs specialist review of both the cyst and the underlying gland.

  • Weight loss with abdominal pain

    This combination alongside a cyst is taken seriously and usually accelerates specialist assessment.

  • Strong family history

    A family history of pancreatic cancer alongside a cyst lowers the threshold for closer surveillance or genetic assessment.

Living with it

A watchful condition, not a frightening one.

Four things that make the biggest difference between scans - keeping appointments, understanding your cyst, staying alert to new symptoms and speaking up about family history.

A quiet reminder

An incidental finding is not the same as a diagnosis of cancer.

Most pancreatic cysts stay stable for years under simple surveillance - the plan exists to catch the small minority that change.

  1. 01 Surveillance

    Keep every scan appointment

    Surveillance imaging only works if it happens on schedule - missed scans mean missed early warning signs.

  2. 02 Understand

    Know your cyst type

    Ask which type of cyst you have and why that particular surveillance interval or plan was chosen for you.

  3. 03 Watch

    Report new symptoms promptly

    New pain, jaundice, weight loss or a change in bowel habits between scans should be reported, not saved for the next appointment.

  4. 04 Escalate

    Ask about family history

    If pancreatic cancer runs in your family, say so - it can change how closely your cyst is watched.

Frequently asked

Everything we get asked about pancreatic cysts.

Quick answers on cyst types, EUS-FNA, surveillance intervals and when surgery is needed.

  • What is a pancreatic cyst?

    A fluid-filled sac that forms in or on the pancreas. Some are pseudocysts related to pancreatitis, while others - serous cystadenomas, mucinous cystic neoplasms and IPMN - are true cystic tumours with different behaviours and risks.

  • Are pancreatic cysts cancerous?

    Most are not. Serous cystadenomas are almost always benign. Mucinous cystic neoplasms and IPMN carry malignant potential, which is why they are risk-stratified and either monitored or removed depending on their features.

  • What is IPMN?

    Intraductal papillary mucinous neoplasm - a cyst that produces mucin and connects to the pancreatic duct system. It can affect the main duct, side branches, or both, and each pattern carries a different level of malignant risk.

  • How are pancreatic cysts diagnosed?

    Usually first seen on a CT or MRI/MRCP done for another reason. Endoscopic ultrasound with fine-needle aspiration (EUS-FNA) then samples the fluid for CEA, amylase and cytology to help confirm the cyst type.

  • Do all pancreatic cysts need surgery?

    No. Many low-risk mucinous and IPMN lesions without worrying features or high-risk stigmata are safely managed with surveillance imaging alone. Surgery is reserved for cysts with features suggesting malignancy or significant malignant potential.

  • How often will I need surveillance imaging?

    It depends on the cyst type, size and risk features, and is set by your specialist HPB team following international consensus guidelines. Intervals commonly range from six months to a couple of years.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.